The project focuses on the condensation of nucleic acids—such as DNA and RNA—through interaction with proteins to develop innovative nanoparticles for intracellular delivery. This research holds strong potential for applications in gene therapy, immunotherapy, and next-generation vaccines.

The initiative builds on the recent discovery of DNA–gelatin microparticles, whose formation and size can be controlled through compositional parameters. The project aims to expand this work by developing nucleic acid–protein nanocoacervates, investigating their structure and formation mechanisms, and evaluating their internalization and transfection efficiency in vitro.

The research will be carried out within the Surface Chemistry Group at IQAC-CSIC, which specializes in nanostructured systems and soft materials, in collaboration with a microbiology research group.

IQAC-CSIC, part of the Spanish National Research Council (CSIC), is a leading multidisciplinary research institute focused on human health, sustainable processes, and advanced materials. It offers state-of-the-art facilities, including advanced laboratories, cell culture units, and computational infrastructure, along with strong expertise in technology transfer.

The call targets candidates holding a PhD in Chemistry, Biochemistry, Pharmacy, or related fields, with experience in colloidal chemistry or nano/microparticles. Applicants must meet MSCA eligibility criteria and submit their applications before 9 September 2026.